Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2013; 19(20): 3062-3068
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3062
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3062
Table 1 Study population baseline characteristics n (%)
Placebo | Glucomannan | |
Patients recruited | 45 | 44 |
Male/female | 21/22 | 21/20 |
Age mean, yr | 11.3 ± 2.5 | 11.6 ± 3.0 |
Self-reported frequency of pain1 | ||
Pain 1-3 times per month | ||
Pain 1-2 times per week | 12 (27.9) | 9 (21.9) |
Pain > 2 times per week | 13 (30.2) | 9 (21.9) |
Pain every day | 14 (32.6) | 14 (34.1) |
4 (9.3) | 9 (21.9) | |
Severity of pain1 | ||
“face 0” | 0 (0) | 0 (0) |
“face 1” | 5 (11.6) | 2 (4.8) |
“face 2” | 18 (40.8) | 13 (31.7) |
“face 3” | 15 (34.8) | 16 (39.0) |
“face 4” | 5 (11.6) | 8 (19.5) |
“face 5” | 0 (0) | 2 (4.8) |
Self-reported absenteeism from school | 21 | 21 |
Self-reported alterations in daily activities | 29 | 27 |
Number of subjects who required rescue therapy | 20 | 25 |
- Citation: Horvath A, Dziechciarz P, Szajewska H. Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: A randomized trial. World J Gastroenterol 2013; 19(20): 3062-3068
- URL: https://www.wjgnet.com/1007-9327/full/v19/i20/3062.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i20.3062